Doxycycline and Autogenous Bone in Repair of Critical-Size Defects

Ribamar Lazanha Lucateli, Marina Angélica Marciano, Sabrina Ferreira, Idelmo Rangel Garcia Júnior, Josette Camilleri, Ronaldo Célio Mariano

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
221 Downloads (Pure)


PURPOSE: The association of doxycycline (DOX) and autogenous bone on repair of critical-size defects was evaluated.

MATERIALS AND METHODS: Fifty albino rats were divided into 5 groups (n = 10). A 5-mm diameter defect was treated with: control (CO)-blood clot; DOX in Natrosol (NAT)-10% gel; NAT-gel; particulate autogenous bone (PAB); and PAB + DOX - PAB associated with 10% DOX gel. The animals were euthanized at 4 and 8 weeks postoperatively. Histomorphometric analysis was performed to assess the percentage of new bone in the defect area. Statistical analysis of the results was performed using analysis of variance and the Tukey test (P < 0.05).

RESULTS: The results showed that new bone formation was limited to the margins of the defect. At 4 and 8 weeks, the group PAB + DOX showed higher bone formation (38.59% and 47.86%, respectively), with statistical difference in comparison with the CO (19.52%) at 4 weeks and CO (18.80%), DOX (22.05%), and NAT (15.89%) at 8 weeks (P < 0.05).

CONCLUSIONS: The association of 10% DOX with autogenous bone significantly improved bone healing in critical-size defects.

Original languageEnglish
JournalImplant dentistry
Early online date1 Jun 2018
Publication statusE-pub ahead of print - 1 Jun 2018


  • Journal Article


Dive into the research topics of 'Doxycycline and Autogenous Bone in Repair of Critical-Size Defects'. Together they form a unique fingerprint.

Cite this